This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Omron Healthcare spotlighted its new global remote patient monitoring services at the 2022 Consumer Electronics Show (CES) and won “Best of” honors for its programs in the U.S. and the U.K. VitalSight by Omron in the U.S. was recognized as an INSIDER “Best of” CES selection; Hypertension Plus by Omron in the U.K. was selected as a TWICE Picks Awards winner for the 2022 TWICE, Residential Systems, and TechRadar Pro Picks Awards.
Omron remote patient monitoring services gained attention and recognition at the world’s largest innovation show as breakthrough health technologies designed to foster greater active health condition management, strengthen the patient-physician connection, and guide behavior change to reduce health risks and advance the company’s mission of Going for Zero, the elimination of heart attack and stroke.
“VitalSight was designed to help the 37 million Americans who have uncontrolled Stage 2 hypertension and live every day with a higher risk of heart attack and stroke, and Omron developed Hypertension Plus as the first step toward transforming chronic care in the U.K.,” says Andre Van Gils, senior general manager, global sales & marketing and executive officer of Omron Healthcare-Japan.
VitalSight is the first remote patient monitoring service from Omron Healthcare, an easy-to-use service that a physician can offer to patients with high-risk levels of hypertension. Patients receive a kit delivered to their home that includes an Omron connected blood pressure monitor and data hub that are preset to securely share measurements digitally with the patient’s physician and care team. The VitalSight data hub, which can be used at home without Wi-Fi or cellular connection, garnered attention at CES for bridging health care gaps for patients in under-resourced communities.
Hypertension Plus by Omron is providing a new way of managing hypertension for patients and connecting them to their physicians and care teams in the U.K. The service provides an app that enables patients to work remotely with their physicians to manage their conditions. Medication decisions and actions are communicated to users through the app, while automated reminders and scheduled condition management actions keep patients engaged in treatment.